All cases | Cases in which the CyA dose was not changed between before and after RCC transfusion | |||||
---|---|---|---|---|---|---|
no. | ρ or η | P | no. | ρ or η | P | |
Sexa | 580 | 0.011 | 0.784 | 252 | 0.053 | 0.402 |
Age | 580 | −0.057 | 0.173 | 252 | −0.027 | 0.672 |
Body weight | 563 | −0.022 | 0.597 | 242 | 0.000 | 0.997 |
Units of RCC transfusion | 580 | 0.026 | 0.534 | 252 | 0.056 | 0.372 |
HCTb | 574 | −0.056 | 0.184 | 251 | −0.026 | 0.681 |
HCTa | 571 | 0.187 | < 0.001b | 245 | 0.240 | < 0.001b |
HCT ratio | 565 | 0.234 | < 0.001b | 244 | 0.273 | < 0.001b |
WBCb | 475 | 0.123 | < 0.01b | 215 | 0.110 | 0.108 |
WBCa | 500 | 0.091 | 0.041b | 214 | 0.105 | 0.125 |
WBC ratio | 447 | −0.002 | 0.970 | 198 | 0.007 | 0.917 |
ASTb | 569 | 0.073 | 0.084 | 247 | 0.129 | 0.042b |
ASTa | 567 | 0.120 | < 0.01b | 242 | 0.161 | 0.012b |
ΔAST | 558 | 0.064 | 0.128 | 239 | 0.144 | 0.026b |
ALTb | 569 | 0.049 | 0.245 | 247 | 0.081 | 0.202 |
ALTa | 567 | 0.080 | 0.057 | 242 | 0.142 | 0.027b |
ΔALT | 558 | 0.095 | 0.025b | 239 | 0.176 | < 0.01b |
ALPb | 539 | 0.048 | 0.268 | 232 | 0.090 | 0.174 |
ALPa | 529 | 0.064 | 0.141 | 224 | 0.118 | 0.079 |
ΔALP | 508 | 0.102 | 0.021b | 216 | 0.146 | 0.032b |
Tbil b | 561 | −0.050 | 0.237 | 246 | −0.027 | 0.675 |
Tbil a | 563 | −0.041 | 0.330 | 242 | 0.043 | 0.507 |
ΔTbil | 548 | 0.048 | 0.259 | 238 | 0.135 | 0.037b |
Alb b | 443 | −0.055 | 0.250 | 184 | −0.143 | 0.052 |
Alb a | 447 | 0.058 | 0.224 | 182 | 0.036 | 0.626 |
ΔAlb | 356 | 0.228 | < 0.001b | 139 | 0.376 | < 0.001b |
Concomitant medicationa: | ||||||
No concomitant medication affecting Ca | 541 | 0.134 | 0.015b | 241 | 0.059 | 0.834 |
Concomitant medication that could elevate Cac | 25 | 5 | ||||
Concomitant medication that could lower Cad | 8 | 5 | ||||
Concomitant medication that could elevate or lower Cae | 6 | 1 |